CompletedPhase 2

A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease

NCT00566397

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Pfizer Investigational Site

Phoenix, Arizona, United States

+61 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2007-12
Enrollment: 402 participants
Sponsor: Pfizer
Purpose: treatment

Locations (62)

Pfizer Investigational SitePhoenix, Arizona, United States
Pfizer Investigational SiteSun City, Arizona, United States
Pfizer Investigational SiteIrvine, California, United States
Pfizer Investigational SiteIrvine, California, United States
Pfizer Investigational SiteIrvine, California, United States
Pfizer Investigational SiteIrvine, California, United States
Pfizer Investigational SiteLa Jolla, California, United States
Pfizer Investigational SiteLos Angeles, California, United States
Pfizer Investigational SiteLos Angeles, California, United States
Pfizer Investigational SiteMartinez, California, United States
Pfizer Investigational SiteNewport Beach, California, United States
Pfizer Investigational SiteOrange, California, United States
Pfizer Investigational SitePalo Alto, California, United States
Pfizer Investigational SiteSacramento, California, United States
Pfizer Investigational SiteSan Diego, California, United States
Pfizer Investigational SiteSan Diego, California, United States
Pfizer Investigational SiteSan Diego, California, United States
Pfizer Investigational SiteSan Francisco, California, United States
Pfizer Investigational SiteSan Francisco, California, United States
Pfizer Investigational SiteSan Francisco, California, United States
Pfizer Investigational SiteVista, California, United States
Pfizer Investigational SiteNew Haven, Connecticut, United States
Pfizer Investigational SiteNew Haven, Connecticut, United States
Pfizer Investigational SiteNew Haven, Connecticut, United States
Pfizer Investigational SiteWashington D.C., District of Columbia, United States
Pfizer Investigational SiteWashington D.C., District of Columbia, United States
Pfizer Investigational SiteWashington D.C., District of Columbia, United States
Pfizer Investigational SiteJacksonville, Florida, United States
Pfizer Investigational SiteMiami Beach, Florida, United States
Pfizer Investigational SiteTampa, Florida, United States
Pfizer Investigational SiteAtlanta, Georgia, United States
Pfizer Investigational SiteChicago, Illinois, United States
Pfizer Investigational SiteChicago, Illinois, United States
Pfizer Investigational SiteIndianapolis, Indiana, United States
Pfizer Investigational SiteLexington, Kentucky, United States
Pfizer Investigational SiteLexington, Kentucky, United States
Pfizer Investigational SiteBaltimore, Maryland, United States
Pfizer Investigational SiteBoston, Massachusetts, United States
Pfizer Investigational SiteAnn Arbor, Michigan, United States
Pfizer Investigational SiteGrand Rapids, Michigan, United States
Pfizer Investigational SiteSt Louis, Missouri, United States
Pfizer Investigational SiteLas Vegas, Nevada, United States
Pfizer Investigational SiteNew York, New York, United States
Pfizer Investigational SiteNew York, New York, United States
Pfizer Investigational SiteNew York, New York, United States
Pfizer Investigational SiteRochester, New York, United States
Pfizer Investigational SiteBeachwood, Ohio, United States
Pfizer Investigational SitePortland, Oregon, United States
Pfizer Investigational SitePhiladelphia, Pennsylvania, United States
Pfizer Investigational SitePittsburgh, Pennsylvania, United States
Pfizer Investigational SiteProvidence, Rhode Island, United States
Pfizer Investigational SiteCharleston, South Carolina, United States
Pfizer Investigational SiteNorth Charleston, South Carolina, United States
Pfizer Investigational SiteNashville, Tennessee, United States
Pfizer Investigational SiteDallas, Texas, United States
Pfizer Investigational SiteHouston, Texas, United States
Pfizer Investigational SiteHouston, Texas, United States
Pfizer Investigational SiteSalt Lake City, Utah, United States
Pfizer Investigational SiteSeattle, Washington, United States
Pfizer Investigational SiteSeattle, Washington, United States
Pfizer Investigational SiteMadison, Wisconsin, United States
Pfizer Investigational SiteMadison, Wisconsin, United States